InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
Board DirectorDisclosed buys
0
Disclosed sells
0
T+90 hit rate
10%
T+90 mean return
-22.0%
Across 10 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the detailed record of transactions filed by Fischel Nathan, Director. Director active across 1 company, notably Stereotaxis, Inc.. In total, 10 disclosures have been published. History available since 1 July 2021. The latest transaction was disclosed on 2 January 2025 (Attribution). Regulator: SEC (Form 4). The full history is free.
Declarations10 total
56,497 shares0Common StockSEC:0001493152-25-000099:0
53,475 shares0Common StockSEC:0001493152-24-025868:0
64,935 shares0Common StockSEC:0001493152-24-000117:0
47,619 shares0Common StockSEC:0001493152-23-023294:0
54,054 shares0Common StockSEC:0001493152-23-000122:0
15,527 shares0Common StockSEC:0001493152-22-018358:0
10,449 shares0Common StockSEC:0001493152-22-000299:0
10,449 shares0Common StockSEC:0001493152-22-000299
30,000 shares0Common StockSEC:0001493152-21-016174
30,000 shares0Common StockSEC:0001493152-21-016174:0
10 of 10 declarations
About Fischel Nathan
Fischel Nathan is a Director at Stereotaxis, Inc. In this role, he contributes to corporate governance and strategic decision-making. His expertise in the medical sector allows him to provide valuable insights during board discussions, ensuring innovation and performance for the company.
